首頁 › 多發性骨髓瘤 › 肯塔基 › Louisville
Louisville, KY 的 多發性骨髓瘤 臨床試驗
12 項針對 多發性骨髓瘤 的研究正在 Louisville（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)
招募中3 期
- Research Site, Louisville
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
招募中3 期
- Norton Cancer Institute, Louisville
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
招募中3 期
- Norton Cancer Institute, Louisville
A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
招募中2 期
- Norton Cancer Institute, Louisville
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
招募中3 期
- Norton Cancer Institute, Louisville
Study to Assess Safety of HDP-101 in Patients With Relapsed Refractory Multiple Myeloma
招募中1/2 期
- Norton Healthcare, Inc., Louisville
Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
招募中2 期
- Norton Women's and Children's Hospital, Louisville
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
招募中3 期
- Research Site, Louisville
A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects
招募中1 期
- Norton Cancer Institute St. Matthews, Louisville
A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment
招募中1/2 期
- Norton Cancer Institute, Louisville
Phase 1/2 Study of Linvoseltamab in Adult Patients With Relapsed or Refractory Multiple Myeloma
招募中1/2 期
- Norton Cancer Institute, Louisville
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
招募中觀察性研究歡迎健康志工
- Baptist Floyd, New Albany · 距離 4 英里
其他城市的 多發性骨髓瘤 試驗
- New York City, NY60 項研究
- Boston, MA42 項研究
- Atlanta, GA42 項研究
- Houston, TX38 項研究
- Durham, NC37 項研究
- Nashville, TN32 項研究
- Denver, CO27 項研究
- Rochester, MN24 項研究
- St. Louis, MO24 項研究
- Columbus, OH24 項研究
- Baldwin Park, CA23 項研究
- Edison, NJ22 項研究
Louisville 的其他研究
- 非小細胞肺癌22 項研究
- 肥胖症17 項研究
- 過重15 項研究
- 癌症（所有類型）14 項研究
- 心臟衰竭13 項研究
- 急性髓系白血病12 項研究
- 卵巢癌12 項研究
- 乳癌11 項研究
- 頭頸部鱗狀細胞癌11 項研究
- 肺癌11 項研究
- 黑色素瘤10 項研究
- 前列腺癌10 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。